Clinical Trial

A Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this study is to investigate the effect of pollen extracts on menopausal symptoms in healthy women The main question it aims to answer is: What is the difference in change in severity of menopausal symptoms as assessed by the total Menopause Rating Scale (MRS) score from baseline at Week 36 between Graminex Water Soluble Pollen Extract (WSPE), Lipid Soluble Pollen Extract (LSPE), and Placebo? Participants will be asked to complete the MRS assessment tool to rate their menopausal symptoms while receiving either WSPE, LSPE, or Placebo.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-17; most recent amendment 2026-07-06.
Status change: Not Yet Recruiting → Recruiting 2025-07-22
Trial Details
NCT Number NCT06889753
Lead Sponsor Graminex LLC
Collaborators: KGK Science Inc.
Conditions Menopausal Women
Enrollment 120 participants
Start Date 2025-10-29
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-08